CEO: | Juho Jalkanen |
Chairman: | Tuomo Pätsi |
Director: | Markku Jalkanen |
Independent Non-Executive Director: | John Poulos |
Non-Executive Dir: | Marie-Louise Fjällskog, Christine Roth |
Address: | Joukahaisenkatu 6, Turku, Finland, FI-20520 |
Phone: | +358 2 469 5151 |
Fax: | +358 2 469 5152 |
Website: | http://www.faronpharmaceuticals.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | FI4000153309 |
Currency | UK Pounds |
Share Price | 248.62p |
Change Today | -16.39p |
% Change | -6.18 % |
52 Week High | 350.00 |
52 Week Low | 117.50 |
Volume | 11,393 |
Shares Issued | 72.01m |
Market Cap | £179.02m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 1 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
09:18 | 1,000 @ 243.00p |
09:18 | 813 @ 243.00p |
09:17 | 1,000 @ 243.00p |
08:58 | 200 @ 242.50p |
08:34 | 2,315 @ 242.50p |
CEO | Juho Jalkanen |
Chair | Tuomo Pätsi |
You are here: research